At our Manhattan practice, were seeing increasing numbers of patients using GLP-1 medications, often without realizing the potential impact these medications can have on mood, anxiety, and overall psychological wellbeing
Readers researching the broader hepatocyte growth factor / c-Met pathway for cognitive indications should be aware that Fosgonimeton (development code ATH-1017), a structurally distinct small-molecule prodrug developed by Athira Pharma as an HGF positive modulator, has been investigated in three clinical trials in dementia indications
It occurs when serum uric acid levels become elevateda condition known as hyperuricaemia leading to the formation of monosodium urate crystals that deposit in and around joints, triggering intense inflammation, swelling, redness, and severe pain
Schedule an informed consultation about regenerative medicine for fibromyalgia, investigational options, safety questions, and coordinated care
Decide where you will inject the GLP-1